Trial site
University General Hospital of Larissa
- 12running trials
- 12closed trials
The trials here
What the 24 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer4 trials
- Lung cancer3 trials
- Epilepsy2 trials
- Heart failure2 trials
- Obesity2 trials
- Primary biliary cholangitis2 trials
- Stroke2 trials
- Acute myeloid leukaemia1 trial
- ALS (motor neurone disease)1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Coronary artery disease1 trial
- and 8 more
- Phase
- Phase 317 trials
- Phase 25 trials
- Status
- Completed10 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Not yet recruiting2 trials
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company5 trials
- Takeda4 trials
- AB Science1 trial
- Amgen1 trial
- Bayer1 trial
- and 12 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Obexelimab in Patients With Relapsing Multiple Sclerosis (MoonStone)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- ALS (motor neurone disease)1 recruiting
- Melanoma1 recruiting
- Metastatic breast cancer1 recruiting
Closed trials
Withdrawn
Completed
PK of BV100 in Patients VABP Suspected or Confirmed to Be Due to CRAB
Terminated
Completed
A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness
Completed
Completed
Completed
Completed
Completed
A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Completed
Completed
Completed
Study of Ibrutinib Combined With Venetoclax in Subjects With Mantle Cell Lymphoma (MCL)
Site data: ClinicalTrials.govUpdated 17 Nov 2026